Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
Yin-Feng Kang, Cong Sun, Zhen Zhuang, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 2738-2752
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
Bahaa Jawad, Puja Adhikari, Rudolf Podgornik, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4425-4441
Open Access | Times Cited: 128
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19
Yue Yin, Wen Su, Jie Zhang, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 14347-14359
Closed Access | Times Cited: 93
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Neil C. Dalvie, Sergio A. Rodriguez‐Aponte, Brittany L. Hartwell, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 38
Open Access | Times Cited: 92
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 7, pp. 1223-1233
Open Access | Times Cited: 79
“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 67
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
Hannah A. D. King, Michael Joyce, Inès Lakhal-Naouar, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 38
Open Access | Times Cited: 60
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Thayne H. Dickey, Wai Kwan Tang, Brandi Butler, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 42
Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 41
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
Yinfeng Kang, Cong Sun, Jing Sun, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 30
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications
Cheng Xu, Hannah E. Dobson, Mengjie Yu, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 84-93
Open Access | Times Cited: 28
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Xiantao Zhang, Shijian Wu, Jie Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 25
Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review
Yang Wang, Kaiwen Yang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125515-125515
Open Access | Times Cited: 24
Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge
Dan Bi Lee, Hyo‐Jin Kim, Ju Hwan Jeong, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 22
Widespread exposure to SARS-CoV-2 in wildlife communities
Amanda R. Goldberg, Kate E. Langwig, Katherine L. Brown, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101445-101445
Open Access | Times Cited: 10
Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses
Wenjiao Fu, Mengyu Guo, Xuemei Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11200-11216
Closed Access | Times Cited: 10
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez‐Aponte, et al.
Science Advances (2022) Vol. 8, Iss. 11
Open Access | Times Cited: 31
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
Cong Sun, Yinfeng Kang, Yuan-Tao Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top